Perspectives and best practices from the world of healthcare and life sciences.

Hybrid co-creation in pharma and biotech

Bringing internal participants together for a hybrid co-creation creates shared intentions and speed to market.

We share best practices in patient communication that may help comply with FDA guidance on informed consent, as well as practical tips.

HCP communications from the pharma industry need to be more focused, trustworthy, and multipurpose, to deliver value in the clinical setting.

The Universal Patient Language (UPL) is an example of how a pharma company can create effective patient communications.

Commercial pharmaceutical teams should examine an array of factors that shape treatment decision-making to influence prescribing behaviour.

Once a month, we send out a newsletter of work-related ideas. Get our next edition delivered to your inbox.